Barclays analyst Steven Valiquette maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report) on April 1 and set a price target of $50.00. The company’s shares closed last Friday at $43.86, close to its 52-week low of $43.18.
According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 1.3% and a 56.4% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Bright Health Group, and AmerisourceBergen.
The word on The Street in general, suggests a Hold analyst consensus rating for Walgreens Boots Alliance with a $50.43 average price target, a 13.2% upside from current levels. In a report issued on April 1, Robert W. Baird also downgraded the stock to Hold with a $51.00 price target.
Based on Walgreens Boots Alliance’s latest earnings release for the quarter ending November 30, the company reported a quarterly revenue of $33.9 billion and net profit of $3.58 billion. In comparison, last year the company earned revenue of $31.44 billion and had a GAAP net loss of $308 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
Read More on WBA:
- Metacrine (MTCR) Gets a Hold Rating from RBC Capital
- Entree Gold (ERLFF) was Upgraded to a Buy Rating at TD Securities
- Marathon Gold (MGDPF) Receives a Buy from Raymond James
- RBC Capital Remains a Hold on Adverum Biotechnologies (ADVM)
- Knight Therapeutics (KHTRF) Gets a Buy Rating from Raymond James